Surgical Resection and Glioblastoma: Molecular Profiling and Safety

被引：3

作者：

Del Maestro, Rolando ^{[1
]}

机构：

[1] McGill Univ, Montreal, PQ, Canada

来源：

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2012年 / 39卷 / 05期

关键词：

ADJUVANT TEMOZOLOMIDE; RADIOTHERAPY; CONCOMITANT; METHYLATION;

D O I：

10.1017/S0317167100015225

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：561 / 562

页数：2

共 12 条

[11] Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial [J].

Stupp, Roger ;

Hegi, Monika E. ;

Mason, Warren P. ;

van den Bent, Martin J. ;

Taphoorn, Martin J. B. ;

Janzer, Robert C. ;

Ludwin, Samuel K. ;

Allgeier, Anouk ;

Fisher, Barbara ;

Belanger, Karl ;

Hau, Peter ;

Brandes, Alba A. ;

Gijtenbeek, Johanna ;

Marosi, Christine ;

Vecht, Charles J. ;

Mokhtari, Karima ;

Wesseling, Pieter ;

Villa, Salvador ;

Eisenhauer, Elizabeth ;

Gorlia, Thierry ;

Weller, Michael ;

Lacombe, Denis ;

Cairncross, J. Gregory ;

Mirimanoff, Rene-Olivier .

LANCET ONCOLOGY, 2009, 10 (05) :459-466

[12] The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations [J].

von Deimling, Andreas ;

Korshunov, Andrey ;

Hartmann, Christian .

BRAIN PATHOLOGY, 2011, 21 (01) :74-87

← 1 2 →